Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/26 17:05 | 8/12/26 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 1 | S.d | -9,241 | 292.07 | 0 | -32 | 28 | D | |||||||||||||||
8/14/26 17:04 | 8/12/26 | LGND | Health | Drug | Pharmaceutical Preparations | Haas Jason | FL | D | 2 | S.d | -3,741 | 275.12 | 0 | -14 | 5 | D | ||||||||||||||||
8/4/26 18:42 | 8/3/26 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 3 | S.d | -4,147 | 276.44 | 0 | -15 | 42 | D | |||||||||||||||
6/18/26 08:37 | 6/16/26 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | 1 | S.d | -545 | 254.00 | 0 | -2 | 34 | D | ||||||||||||||||
6/12/26 17:27 | 6/10/26 | LGND | Health | Drug | Pharmaceutical Preparations | Aryeh Jason | FL | D | 1 | S.dm | -1,250 | 250.00 | 0 | -5 | 116 | D | ||||||||||||||||
6/12/26 17:26 | 6/10/26 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | FL | D | 1 | S | -1,152 | 250.88 | 0 | -5 | 27 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |